Robert Braun

Corporate and Business Development Executive

Greater Boston

About

Accomplished corporate development executive in the healthcare industry with a demonstrated record of executing transactions that deliver on strategic and financial initiatives. Successfully led the business development process and cross functional deal teams from the strategic assessment of potential partners through due diligence and deal execution. Acquired broad transactional experience through roles in corporate development by structuring and negotiating deals of all types as well as gaining significant experience in the financial modeling of complex transactions.

Experience

  • Senior Director Mergers and Acquisitions (Coporate Development) at Philips
    2021 - 2024 · 3 yrs

    Led Corporate Development activities for several business units. Responsibilities included partnering with senior internal stakeholders to develop business cases, leading cross functional teams through due diligence, strategic evaluation and financial modeling of targets, developing deal structures, negotiating term sheets and definitive agreements with external partners, and presenting proposals to senior management for approval.

  • Director Corporate Development at Zimmer Biomet
    2017 - 2021 · 4 yrs

    Led the Corporate Development activities for several orthopedic business units. Responsible for managing the business development process to drive growth through external partnering opportunities.

  • Senior Director, Business Development and Strategy at Medtronic
    2015 - 2017 · 2 yrs

    Led Business Development & Strategy for the Integrated Health Solutions business unit in the Americas.

  • Senior Director Business Development at Allergan
    2008 - 2014 · 6 yrs

    Led business development for the Medical Aesthetics business unit including the Plastic Surgery, Facial Aesthetics and Obesity Intervention businesses.

  • Director, Corporate Development at Boston Scientific
    2005 - 2008 · 3 yrs

    Led corporate development activities for the global Cardiac Rhythm Management and Vascular Surgery therapeutic areas.